PURE Bioscience, Inc. (PURE) Operating income 2017–2026
PURE Bioscience, Inc. (PURE) annual operating income history from SEC filings — each fiscal year as reported.
-$2.1MFY2026 · since FY2017: -$6.0M → -$2.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$2.1M | +8.3% |
| FY2025 | -$2.3M | +28.8% |
| FY2024 | -$3.2M | +19.1% |
| FY2023 | -$3.9M | -5.9% |
| FY2022 | -$3.7M | -61.1% |
| FY2021 | -$2.3M | -57875.0% |
| FY2020 | $4,000 | +100.1% |
| FY2019 | -$5.6M | +20.6% |
| FY2018 | -$7.0M | -17.2% |
| FY2017 | -$6.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PURE financial trends
PURE RevenuePURE Net incomePURE Net marginPURE Gross profitPURE Gross marginPURE Operating marginPURE Operating cash flowPURE Free cash flowPURE Capital expendituresPURE Return on equityPURE Stock buybacksPURE Dividends paidPURE Total assetsPURE Total liabilitiesPURE Shareholders’ equityPURE overview →